1. Home
  2. ABCL vs FIGS Comparison

ABCL vs FIGS Comparison

Compare ABCL & FIGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

N/A

Current Price

$9.66

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Logo FIGS Inc.

FIGS

FIGS Inc.

N/A

Current Price

$19.84

Market Cap

3.4B

ML Signal

N/A

Company Overview

Basic Information
Metric
ABCL
FIGS
Founded
2012
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.4B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ABCL
FIGS
Price
$9.66
$19.84
Analyst Decision
Strong Buy
Buy
Analyst Count
14
10
Target Price
$18.69
★ $23.22
AVG Volume (30 Days)
2.8M
★ 3.5M
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
10.91
★ 850.00
EPS
N/A
★ 0.28
Revenue
$75,128,000.00
★ $419,591,000.00
Revenue This Year
N/A
$23.67
Revenue Next Year
$13.74
$10.78
P/E Ratio
★ N/A
$72.71
Revenue Growth
★ 160.56
59.47
52 Week Low
$2.75
$9.17
52 Week High
$14.98
$23.77

Technical Indicators

Market Signals
Indicator
ABCL
FIGS
Relative Strength Index (RSI) 34.01 47.45
Support Level $3.45 $19.41
Resistance Level $12.91 $23.11
Average True Range (ATR) 0.84 1.34
MACD -0.22 -0.43
Stochastic Oscillator 2.41 8.38

Price Performance

Historical Comparison
ABCL
FIGS

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About FIGS FIGS Inc.

FIGS Inc is a healthcare apparel company. It designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other healthcare apparel. The company sells products mainly through its direct-to-consumer (DTC) digital platform, consisting of its website, mobile app, and B2B business (TEAMS). It also operates physical retail stores, which are called Community Hubs, providing a retail experience for healthcare professionals. The company generates maximum revenue from the sale of scrubwear products. Geographically, it derives maximum revenue from the United States, followed by the rest of the world.

Share on Social Networks: